Year: 2025
Type: article
Abstract: The synthesis of cannabigerol—a cannabinoid with significant pharmaceutical potential—is described. The synthesis involves four stages. In the first step, (E)-non-3-en-2-one reacts with dimethyl malonate to yield a cyclic enone, which is subsequently oxidized with bromine to produce the olivetol ester. This ester then undergoes an alumina-catalyzed coupling reaction with geraniol, followed by ester hydrolysis to obtain cannabigerol. By modifying the chain length of the enone in the initial step and employing allylic alcohols other than geraniol, a range of cannabigerol derivatives can be synthesized, including the natural product cannabigerovarin.
Source: Organics
DOI: 10.3390/org6030031
Authors: Juan F. Ortuño, Alessio Ghisolfi, Raquel Almansa, Olga Soares do Rego Barros, Ana Sirvent, José M. Sansano, Francisco Foubelo
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,207
Funder: Universidad de Alicante
Awards: G3859476581, G4681437127, G6378746755
OpenAlex ID: W4412477436
